本品含有10%的左旋C精华。左旋C是人体无法自行合成的,而且是人体唯一一种不需经转化就能直接被吸收利用的维生素C。皮肤吸收左旋C后,肌肤内的维生素C含量可以达到平常时的十到十四倍,使肌肤能够更加有效抗氧化,避免被自由基伤害;同时左旋C还可以促进人体胶原蛋白和弹性纤维的合成速度,从而帮助肌肤快速恢复弹性、减少皱纹生成、美白肌肤。本品还添加了促进细胞活化的氨基酸、锌和葡萄籽精华等成份,加速新陈代谢,使您的肌肤快速恢复年轻无痕、健康靓丽。
Cellex C高浓度左旋C精华眼霜还具有以下几个特点:
- 适合除敏感皮肤者外所有肤质者使用
- Cellex C专利产品容易涂抹,能够被皮肤快速吸收, 使您的肌肤如丝般光滑,焕发自然光泽
- 为肌肤提供天然的液体滋养成份,增加肌肤弹性,防止肌肤松弛老化
水、抗坏血酸维生素C(左旋维生素C)、锌酸/三酸甘油脂、甘油、鲸蜡硬酯-20、酪氨酸、硬酯酸、鲸蜡醇、乳化蜡、聚二甲基矽氧烷、硫酸锌、月见草精油、甘氨酸、葡萄叶萃取物、葡萄籽萃取物、鲸蜡硬酯醇、维生素E醋酸酯、洋甘菊萃取物、库拉索芦荟凝胶、卵磷脂、苯氧乙醇、依地酸二钠、聚山梨酯20、香料。
1. 彻底清洁肌肤,收敛毛孔。
2. 可在使用眼霜前涂抹玻尿酸高保湿凝胶于脸部及眼部周围,以便肌肤充分吸收眼霜。
3. 每日清晨使用一次,提取少量Cellex C高浓度左旋C精华眼霜涂抹于下眼睑及眼眶周围。请避免涂于上眼睑、眉毛及眼睛内外眼角处。
4. 如需额外保湿滋养,可选用G.L.A高效保湿眼霜。* 佩戴隐形眼镜者,请先戴好隐形眼镜后再使用本品。
Shapiro, Stanley S., and Claude Saliou. "Role of vitamins in skin care."Nutrition 17.10 (2001): 839-844.http://www.sciencedirect.com/science/article/pii/S0899900701006608
Albacarys, Lourdes Dessus, David Michael McAtee, and George Endel Deckner. "Cleansing articles for skin and/or hair which also deposit skin care actives." U.S. Patent No. 6,338,855. 15 Jan. 2002.http://www.google.com/patents/US6338855
Fujinami, Yoshihito, Akihiro Tai, and Itaru Yamamoto. "Radical scavenging activity against 1, 1-diphenyl-2-picrylhydrazyl of ascorbic acid 2-glucoside (AA-2G) and 6-acyl-AA-2G." CHEMICAL AND PHARMACEUTICAL BULLETIN-TOKYO- 49.5 (2001): 642-644.http://cpb.pharm.or.jp/cpb/200105/c05_0642.pdf?origin=publication_detail, Shapiro, Stanley S., and Claude Saliou. "Role of vitamins in skin care."Nutrition 17.10 (2001): 839-844.
http://www.sciencedirect.com/science/article/pii/S0899900701006608
Albacarys, Lourdes Dessus, David Michael McAtee, and George Endel Deckner. "Cleansing articles for skin and/or hair which also deposit skin care actives." U.S. Patent No. 6,338,855. 15 Jan. 2002.
http://www.google.com/patents/US6338855
Fujinami, Yoshihito, Akihiro Tai, and Itaru Yamamoto. "Radical scavenging activity against 1, 1-diphenyl-2-picrylhydrazyl of ascorbic acid 2-glucoside (AA-2G) and 6-acyl-AA-2G." CHEMICAL AND PHARMACEUTICAL BULLETIN-TOKYO- 49.5 (2001): 642-644.
http://cpb.pharm.or.jp/cpb/200105/c05_0642.pdf?origin=publication_detail